The CD44s Isoform is a Potential Biomarker for Predicting Craniopharyngioma Recurrence in Children
NeuroMolecular Medicine · 2024
DOI: 10.1007/s12017-024-08797-y ↗Kurz gefasst
Fachartikel in der Zeitschrift NeuroMolecular Medicine, 2024. Verfasst von K Bajdak-Rusinek und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Medykow 18 Street, 40-752, Katowice, Poland. …. Hauptthemen laut MEDLINE: Hyaluronan Receptors, Craniopharyngioma, Biomarkers, Tumor, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institutional grant of Medical University of Silesia.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Adamantinomatous craniopharyngioma (ACP) is an intracranial tumor considered partly malignant due to its ability to infiltrate surrounding structures and tendency to relapse despite radical resection. CD44 is a known stem cell marker in ACP and is upregulated in cell clusters of invasive ACP protrusions; however, the functions of its alternative splicing isoform variants, CD44s and CD44v1-10, have not yet been studied in terms of ACP recurrence, despite their confirmed roles in cancer development and progression. In this study, we first confirmed the difference in total CD44 expression between samples from patients who experienced relapse and those from patients who did not. Moreover, our findings showed that, in recurrent samples, the predominant isoform expressed was CD44s, which might indicate its significance in predicting ACP recurrence. The association between increased CD44 expression and recurrence may lead to the development of prognostic markers of ACP aggressiveness and relapse potential; however, further studies are needed to clarify the exact mechanism of CD44 expression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Genetics, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Medykow 18 Street, 40-752, Katowice, Poland. kbajdak-rusinek@sum.edu.pl.
- Department of Medical Genetics, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Medykow 18 Street, 40-752, Katowice, Poland.
- Biotechnology Centre, Silesian University of Technology, Gliwice, Poland.
- Department of Pathomorphology and Molecular Diagnostics, Medical University of Silesia, 40-752, Katowice, Poland.
- Department of Pediatrics and Pediatric Endocrinology, Faculty of Medical Science, Medical University of Silesia, Katowice, Poland.
- Students Scientific Society, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland.
Förderung
- Institutional grant of Medical University of Silesia
Zitieren
APA
Bajdak-Rusinek, K., Diak, N., Gutmajster, E., Fus-Kujawa, A., Ciupińska, M., Kalina-Faska, B., Trybus, A., Grajek, M., Kalina, M., & Mandera, M. (2024). The CD44s Isoform is a Potential Biomarker for Predicting Craniopharyngioma Recurrence in Children. NeuroMolecular Medicine. https://doi.org/10.1007/s12017-024-08797-y
Vancouver
Bajdak-Rusinek K, Diak N, Gutmajster E, Fus-Kujawa A, Ciupińska M, Kalina-Faska B, et al. The CD44s Isoform is a Potential Biomarker for Predicting Craniopharyngioma Recurrence in Children. NeuroMolecular Medicine. 2024. doi:10.1007/s12017-024-08797-y
BibTeX
@article{BajdakRusinek2024,
author = {Bajdak-Rusinek, K and Diak, N and Gutmajster, E and Fus-Kujawa, A and Ciupińska, M and Kalina-Faska, B and Trybus, A and Grajek, M and Kalina, M and Mandera, M},
title = {The CD44s Isoform is a Potential Biomarker for Predicting Craniopharyngioma Recurrence in Children},
journal = {NeuroMolecular Medicine},
year = {2024},
doi = {10.1007/s12017-024-08797-y}
}
EUVIMED